Successful Stereotactic Body Radiation Therapy for Postbrachytherapy Prostate Recurrence and Penile Bulb Metastasis

Deborah E. Citrin, Erica Schott, Kilian Salerno, Holly Ning, Peter A. Pinto, Bradford J. Wood, Liza Lindenberg, Esther Mena, Barış TürkbeyAdvances 2021 · DOI

Abstract

Brachytherapy is a highly effective therapy for low-risk localized prostate cancer, with excellent biochemical control rates achieved in patients with localized disease.1 Local recurrence after low dose rate prostate brachytherapy can be challenging to identify owing to the metal artifact caused by brachytherapy seeds that interferes with prostate magnetic resonance imaging (MRI), although this can be partially overcome with multiparametric MRI (mpMRI).2 Recent developments in advanced imaging of prostate cancer, such as prostate-specific membrane antigen (PSMA)–based positron emission tomography (PET) imaging, has provided new insights into the patterns of recurrence after definitive treatment with external beam irradiation, prostate brachytherapy, and surgery.
BibTeX
@inproceedings{citrin2021successful,
  author = {Deborah E. Citrin and Erica Schott and Kilian Salerno and Holly Ning and Peter A. Pinto and Bradford J. Wood and Liza Lindenberg and Esther Mena and Barış Türkbey},
  title = {{Successful Stereotactic Body Radiation Therapy for Postbrachytherapy Prostate Recurrence and Penile Bulb Metastasis}},
  booktitle = {Advances},
  year = {2021},
  doi = {10.1016/j.adro.2021.100860},
}

Loading related content...

Figure